AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
A DOSE-FINDING STUDY FOR THE COMBINATION OF EPIDOXORUBICIN AND VINORELBINE, DELIVERED EVERY 2 WEEKS WITH G-CSF SUPPORT, IN ADVANCED BREAST-CANCER
Authors: PRONZATO P TOGNONI A PENSA F VAIRA F VIGANI A
Citation: P. Pronzato et al., A DOSE-FINDING STUDY FOR THE COMBINATION OF EPIDOXORUBICIN AND VINORELBINE, DELIVERED EVERY 2 WEEKS WITH G-CSF SUPPORT, IN ADVANCED BREAST-CANCER, Journal of chemotherapy, 10(4), 1998, pp. 326-330
A PHASE-II TRIAL OF CARBOPLATIN, METHOTREXATE AND FLUOROURACIL IN FLUOROURACIL-PRETREATED COLORECTAL-CANCER
Authors: PRONZATO P BOTTO F GHIO E PENSA F TOGNONI A VAIRA F VIGANI A NERI E
Citation: P. Pronzato et al., A PHASE-II TRIAL OF CARBOPLATIN, METHOTREXATE AND FLUOROURACIL IN FLUOROURACIL-PRETREATED COLORECTAL-CANCER, Journal of chemotherapy, 10(3), 1998, pp. 254-257
TUMOR PROLIFERATIVE ACTIVITY EVALUATED WITH THYMIDINE LABELING INDEX PREDICTS RESPONSE TO ADJUVANT CHEMOTHERAPY
Authors: PRONZATO P SERTOLI MR VENTURINI M DELMASTRO L QUEIROLO P VIGANI A ROSSO R
Citation: P. Pronzato et al., TUMOR PROLIFERATIVE ACTIVITY EVALUATED WITH THYMIDINE LABELING INDEX PREDICTS RESPONSE TO ADJUVANT CHEMOTHERAPY, European journal of cancer, 34, 1998, pp. 29-29
HIGH-DOSE-INTENSITY COMBINATION CHEMOTHERAPY FOR ADVANCED SARCOMAS - A PILOT-STUDY
Authors: PRONZATO P LOSARDO P PENSA F TOGNONI A
Citation: P. Pronzato et al., HIGH-DOSE-INTENSITY COMBINATION CHEMOTHERAPY FOR ADVANCED SARCOMAS - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 513-516
HIGH-DOSE INTENSITY CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, VINCRISTINE ANDPREDNISONE BY SHORTENED INTERVALS AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY
Authors: PRONZATO P LIONETTO R BOTTO F PENSA F TOGNONI A
Citation: P. Pronzato et al., HIGH-DOSE INTENSITY CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, VINCRISTINE ANDPREDNISONE BY SHORTENED INTERVALS AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY, British Journal of Cancer, 78(6), 1998, pp. 777-780
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN LOW-DOSES AND INTENSITY OF CHEMOTHERAPY
Authors: PRONZATO P PENSA F VAIRA F VIGANI A
Citation: P. Pronzato et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN LOW-DOSES AND INTENSITY OF CHEMOTHERAPY, Tumori, 83(5), 1997, pp. 8-12
A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER
Authors: BALDINI E GARDIN G GIANNESSI P BREMA F CAMORRIANO A CARNINO F NASO C PASTORINO G PRONZATO P ROSSO R RUBAGOTTI A TORRETTA G CONTE PF
Citation: E. Baldini et al., A RANDOMIZED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN LOCALLY ADVANCED BREAST-CANCER, Tumori, 83(5), 1997, pp. 829-833
2ND LINE CHEMOTHERAPY WITH IFOSFAMIDE AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER
Authors: PRONZATO P VIGANI A PENSA F VANOLI M TANI F VAIRA F
Citation: P. Pronzato et al., 2ND LINE CHEMOTHERAPY WITH IFOSFAMIDE AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER, American journal of clinical oncology, 20(5), 1997, pp. 519-521
A NEW SCHEDULE FOR ETOPOSIDE, EPIDOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED GASTRIC-CANCER - A FEASIBILITY STUDY
Authors: PRONZATO P VIGANI A PENSA F BOTTO F GHIO E NERI E TOGNONI A VAIRA F
Citation: P. Pronzato et al., A NEW SCHEDULE FOR ETOPOSIDE, EPIDOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED GASTRIC-CANCER - A FEASIBILITY STUDY, Anticancer research, 17(5B), 1997, pp. 3873-3876
INTENSIFIED M-VEC CHEMOTHERAPY WITH G-CSF SUPPORT AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER
Authors: PRONZATO P BERTELLI G BRUNA F TANI F VAIRA F VANOLI M VIGANI A
Citation: P. Pronzato et al., INTENSIFIED M-VEC CHEMOTHERAPY WITH G-CSF SUPPORT AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER, Anticancer research, 17(3C), 1997, pp. 2325-2327
PHASE-II STUDY OF VINORELBINE AND IFOSFAMIDE IN ANTHTRACYCLINE RESISTANT METASTATIC BREAST-CANCER
Authors: PRONZATO P QUEIROLO P LANDUCCI M VAIRA F VIGANI A GIPPONI M CAFIERO F
Citation: P. Pronzato et al., PHASE-II STUDY OF VINORELBINE AND IFOSFAMIDE IN ANTHTRACYCLINE RESISTANT METASTATIC BREAST-CANCER, Breast cancer research and treatment, 42(2), 1997, pp. 183-186
COMBINED CISPLATIN, DOXORUBICIN, AND MITOMYCIN FOR THE TREATMENT OF ADVANCED PLEURAL MESOTHELIOMA - A PHASE-II FONICAP TRIAL
Authors: PENNUCCI MC ARDIZZONI A PRONZATO P FIORETTI M LANFRANCO C VERNA A GIORGI G VIGANI A FROLA C ROSSO R
Citation: Mc. Pennucci et al., COMBINED CISPLATIN, DOXORUBICIN, AND MITOMYCIN FOR THE TREATMENT OF ADVANCED PLEURAL MESOTHELIOMA - A PHASE-II FONICAP TRIAL, Cancer, 79(10), 1997, pp. 1897-1902
INTERLEUKIN-2 AND INTERFERON-ALPHA-2 COMBINATION - INEFFECTIVENESS OFA SINGLE 6-WEEK COURSE IN PATIENTS WITH METASTATIC RENAL-CANCER PRETREATED WITH INTERFERON ALONE
Authors: PRONZATO P VIGANI A VAIRA F TANI F VANOLI M
Citation: P. Pronzato et al., INTERLEUKIN-2 AND INTERFERON-ALPHA-2 COMBINATION - INEFFECTIVENESS OFA SINGLE 6-WEEK COURSE IN PATIENTS WITH METASTATIC RENAL-CANCER PRETREATED WITH INTERFERON ALONE, Oncology Reports, 3(6), 1996, pp. 1137-1139
TROPISETRON-DEXAMETHASONE COMBINATION FOR CARBOPLATIN-INDUCED EMESIS
Authors: PRONZATO P GHIO E LOSARDO PL VAIRA F VIGANI A
Citation: P. Pronzato et al., TROPISETRON-DEXAMETHASONE COMBINATION FOR CARBOPLATIN-INDUCED EMESIS, Oncology Reports, 3(6), 1996, pp. 1179-1181
LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: GARDIN G BARONE C NASCIMBEN O IANNIELLO G STURBA F CONTU A PRONZATO P ROSSO R
Citation: G. Gardin et al., LONIDAMINE PLUS EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 32A(1), 1996, pp. 176-177
CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO)
Authors: CONTE PF BALDINI E GARDIN G PRONZATO P AMADORI D CARNINO F MONZEGLIO C GENTILINI P GALLOTTI P DEMICHELI R VENTURINI M RUBAGOTTI A ROSSO R
Citation: Pf. Conte et al., CHEMOTHERAPY WITH OR WITHOUT ESTROGENIC RECRUITMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL OF THE GRUPPO-ONCOLOGICO-NORD-OVEST (GONO), Annals of oncology, 7(5), 1996, pp. 487-490
MULTICENTER RANDOMIZED CONTROLLED CLINICAL-TRIAL TO EVALUATE CARDIOPROTECTION OF DEXRAZOXANE VERSUS NO CARDIOPROTECTION IN WOMEN RECEIVING EPIRUBICIN CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
Authors: VENTURINI M MICHELOTTI A DELMASTRO L GALLO L CAMINO F GARRONE O TIBALDI C MOLEA N BELLINA RC PRONZATO P CYRUS P VINKE J TESTORE F GUELFI M LIONETTO R BRUZZI P CONTE PF ROSSO R
Citation: M. Venturini et al., MULTICENTER RANDOMIZED CONTROLLED CLINICAL-TRIAL TO EVALUATE CARDIOPROTECTION OF DEXRAZOXANE VERSUS NO CARDIOPROTECTION IN WOMEN RECEIVING EPIRUBICIN CHEMOTHERAPY FOR ADVANCED BREAST-CANCER, Journal of clinical oncology, 14(12), 1996, pp. 3112-3120
CARBOPLATIN AND VINORELBINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: PRONZATO P GHIO E LOSARDO PL LANDUCCI M VAIRA F VIGANI A
Citation: P. Pronzato et al., CARBOPLATIN AND VINORELBINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 610-612
TAMOXIFEN AND INTERFERON-BETA FOR THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: REPETTO L GIANNESSI PG CAMPORA E PRONZATO P VIGANI A NASO C SPINELLI I CONTE PF ROSSO R
Citation: L. Repetto et al., TAMOXIFEN AND INTERFERON-BETA FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Breast cancer research and treatment, 39(2), 1996, pp. 235-238
A FEASIBILITY STUDY OF ACCELERATED POLYCHEMOTHERAPY WITH CISPLATIN, EPIDOXORUBICIN AND CYCLOPHOSPHAMIDE (PEG) IN ADVANCED OVARIAN-CANCER
Authors: PRONZATO P BERTELLI G VIGANI A VAIRA F
Citation: P. Pronzato et al., A FEASIBILITY STUDY OF ACCELERATED POLYCHEMOTHERAPY WITH CISPLATIN, EPIDOXORUBICIN AND CYCLOPHOSPHAMIDE (PEG) IN ADVANCED OVARIAN-CANCER, British Journal of Cancer, 73(11), 1996, pp. 1425-1427
LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER - ANALYSIS OF PROGNOSTICFACTORS IN 125 PATIENTS HOMOGENEOUSLY TREATED WITH A COMBINED-MODALITY APPROACH
Authors: GARDIN G ROSSO R CAMPORA E REPETTO L NASO C CANAVESE G CATTURICH A CORVO R GUENZI M PRONZATO P BALDINI E CONTE PF
Citation: G. Gardin et al., LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER - ANALYSIS OF PROGNOSTICFACTORS IN 125 PATIENTS HOMOGENEOUSLY TREATED WITH A COMBINED-MODALITY APPROACH, European journal of cancer, 31A(9), 1995, pp. 1428-1433
METHOTREXATE (MTX) AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CANCER PATIENTS PREVIOUSLY TREATED WITH ADJUVANT 5-FU
Authors: PRONZATO P VAIRA F VIGANNI A LOSARDO P BERTELLI G
Citation: P. Pronzato et al., METHOTREXATE (MTX) AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CANCER PATIENTS PREVIOUSLY TREATED WITH ADJUVANT 5-FU, European journal of cancer, 31A, 1995, pp. 760-760
GRANISETRON (G)-DEXAMETHASONE (D) COMBINATION FOR MULTIPLE DAY CISPLATIN (C)
Authors: LOSARDO PL LANDUCCI M VIGANI A VAIRA F CANTINOTTI E PRONZATO P
Citation: Pl. Losardo et al., GRANISETRON (G)-DEXAMETHASONE (D) COMBINATION FOR MULTIPLE DAY CISPLATIN (C), European journal of cancer, 31A, 1995, pp. 1242-1242
RANDOMIZED COOPERATIVE STUDY OF PERIOPERATIVE CHEMOTHERAPY IN BREAST-CANCER
Authors: SERTOLI MR BRUZZI P PRONZATO P QUEIROLO P AMOROSO D DELMASTRO L VENTURINI M VIGANI A BERTELLI G CAMPORA E BOCCARDO F MONZEGLIO C PAGANINI E PASTORINO G CANAVESE G CATTURICH A CAFIERO F VECCHIO C MICCOLI P RUBAGOTTI A ROSSO R
Citation: Mr. Sertoli et al., RANDOMIZED COOPERATIVE STUDY OF PERIOPERATIVE CHEMOTHERAPY IN BREAST-CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2712-2721
CARBOPLATIN, METHOTREXATE, AND VINBLASTINE IN OUTPATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: PRONZATO P LANDUCCI M VAIRA F VIGANI A BERTELLI G
Citation: P. Pronzato et al., CARBOPLATIN, METHOTREXATE, AND VINBLASTINE IN OUTPATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, American journal of clinical oncology, 18(3), 1995, pp. 223-225
Risultati: 1-25 | 26-39